FIC Capital’s Integra LifeSciences IART Stock Holding History

FIC Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-53,266	Closed	-$1.8M	–	123
2015 Q4	$1.8M	Sell	53,266 -3,270	-6%	-$102K	0.8%	40
2015 Q3	$1.68M	Sell	56,536 -13,758	-20%	-$430K	0.79%	39
2015 Q2	$1.94M	Sell	70,294 -367	-0.5%	-$9.78K	0.77%	43
2015 Q1	$1.78M	Sell	70,661 -86	-0.1%	-$2.03K	0.68%	46
2014 Q4	$1.57M	Hold	70,747	–	–	0.61%	53
2014 Q3	$1.44M	Sell	70,747 -1,089	-2%	-$21.7K	0.57%	58
2014 Q2	$1.38M	Buy	+71,836	New	+$1.34M	0.54%	64

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

FIC Capital's IART Position: Q1 2016 in Review

FIC Capital sold out of Integra LifeSciences (IART) in Q1 2016, closing a stake of 53,266 shares — an estimated $1.8M sold.

FIC Capital first reported a position in IART in Q2 2014 and held it in 7 quarters. The position peaked at $1.94M in Q2 2015. 194 funds tracked by Wall St. Rank hold IART as of Q1 2016.

FIC Capital reported no remaining Integra LifeSciences position as of Q1 2016 after selling out during the quarter.
FIC Capital sold 53,266 Integra LifeSciences shares in Q1 2016, an estimated $1.8M.
FIC Capital first reported a position in Integra LifeSciences in Q2 2014 and held it in 7 quarters.
FIC Capital's Integra LifeSciences position peaked at $1.94M in Q2 2015.
194 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2016.

Based on FIC Capital's 13F filing for Q1 2016, filed 12 May 2016.